Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Case Study—Nanosuspension Formulation to Maximize Potency for Preclinical Studies
New Findings on the Sinclair Nanopig™ in Safety Studies
Recent Scientific Data Challenges the Status Quo
Our most recent white paper presents detailed genomic, proteomic, and functional data on the Sinclair Nanopig™’s metabolism and immune systems. These findings validate this animal model as a valuable tool for regulatory pharmacology and drug safety, enhancing cross-species assessments and improving understanding of drug metabolism and potential toxicities.
The groundbreaking data also supports the use of the Sinclair Nanopig™ to reduce reliance on traditional non-rodent models in drug development.
Questions? Consult with one of our experts.
You may also be interested in the following resources:
Getting to the Heart of Science With Talita Conte, Scientific Project Manager
The Stories That Inspire
Meet Talita Conte, one of our dedicated scientific project managers. From São Paulo to Montréal, her journey is a testament to the power of passion and innovation in science. After making a breakthrough in myotonic dystrophy type 1 published in Nature Communications, she transitioned to project management at Altasciences, where she continues to drive fast-paced, impactful clinical trials.
How We Used Singlicate Analysis to Optimize Resource Utilization
Achieving Efficiency and Cost Savings in Drug Development
In the fast-paced world of drug development, where every sample counts, finding ways to optimize resources and accelerate results is critical.
In this poster presentation, we discuss singlicate analysis, an innovative approach that focuses on individual samples to streamline processes. This method is ideal for managing the data-intensive demands of drug discovery, whether in the GLP or non-GLP phases. It's particularly effective across various matrices, drug entities, and biomarkers.
Watch to find out how we slashed consumable costs, maximized resource utilization, and accelerated data generation.
If you want to enhance efficiency without compromising on data quality, singlicate analysis could be the game-changer your studies need.
Speak with an expert to learn more about how this approach can be tailored to your specific needs.
You may also be interested in the below poster presentations:
- Sensitive Quantitation of ASOs Using Microsampling Coupled with Hybridization LC-MS/MS
- Development of an Assay for Atropine in Rabbit Plasma by LC-MS/MS and the Impact of Atropine Esterase
- Strategies to Improve Assay Sensitivity to Quantify Therapeutic Oligonucleotides
Inside The Altascientist Issue 33: CNS Drug Development – Integrated Solutions Lessen Complexity